BOK Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52
| Closed | -$14K | – | 1153 |
|
|
2025
Q1 | $14K | Sell |
52
-329
| -86% | -$88.8K | ﹤0.01% | 956 |
|
|
2024
Q4 | $90.7K | Buy |
381
+326
| +593% | +$77.6K | ﹤0.01% | 759 |
|
|
2024
Q3 | $14.8K | Sell |
55
-5,696
| -99% | -$1.54M | ﹤0.01% | 952 |
|
|
2024
Q2 | $1.4M | Sell |
5,751
-961
| -14% | -$234K | 0.03% | 420 |
|
|
2024
Q1 | $1.03M | Buy |
6,712
+1,295
| +24% | +$199K | 0.02% | 475 |
|
|
2023
Q4 | $1.04M | Sell |
5,417
-1,305
| -19% | -$250K | 0.02% | 452 |
|
|
2023
Q3 | $1.02M | Buy |
6,722
+1,706
| +34% | +$259K | 0.02% | 433 |
|
|
2023
Q2 | $953K | Sell |
5,016
-149
| -3% | -$28.3K | 0.02% | 467 |
|
|
2023
Q1 | $1.03M | Sell |
5,165
-492
| -9% | -$98.6K | 0.02% | 451 |
|
|
2022
Q4 | $1.34M | Sell |
5,657
-2,350
| -29% | -$558K | 0.02% | 446 |
|
|
2022
Q3 | $1.6M | Sell |
8,007
-875
| -10% | -$175K | 0.03% | 402 |
|
|
2022
Q2 | $1.3M | Buy |
+8,882
| New | +$1.3M | 0.02% | 463 |
|
|
2020
Q3 | – | Sell |
-6,094
| Closed | -$903K | – | 855 |
|
|
2020
Q2 | $903K | Buy |
+6,094
| New | +$903K | 0.02% | 480 |
|
|
2015
Q2 | – | Sell |
-12,051
| Closed | -$1.26M | – | 858 |
|
|
2015
Q1 | $1.26M | Buy |
+12,051
| New | +$1.26M | 0.04% | 400 |
|